BENJAMIN EDWARDS INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
BENJAMIN EDWARDS INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27
-12.9%
844
+10.2%
0.01%
-14.3%
Q2 2023$31
+10.7%
766
+2.4%
0.01%0.0%
Q1 2023$28
+12.0%
748
+5.4%
0.01%0.0%
Q4 2022$25
-99.9%
710
+24.8%
0.01%
-30.0%
Q3 2022$32,0000.0%569
-7.2%
0.01%
+11.1%
Q2 2022$32,000
-27.3%
613
+1.0%
0.01%
-30.8%
Q1 2022$44,000
-45.7%
607
-11.8%
0.01%
-50.0%
Q4 2021$81,000
-6.9%
688
+5.5%
0.03%
-50.9%
Q3 2021$87,000
-37.0%
652
-23.3%
0.05%
-44.2%
Q2 2021$138,000
+32.7%
850
-34.3%
0.10%
+20.3%
Q1 2021$104,000
+46.5%
1,293
-0.6%
0.08%
+43.6%
Q4 2020$71,000
+86.8%
1,301
-31.3%
0.06%
+77.4%
Q3 2020$38,0000.0%1,894
+4.2%
0.03%
-3.1%
Q2 2020$38,000
+72.7%
1,8170.0%0.03%
+39.1%
Q1 2020$22,000
-21.4%
1,817
-3.2%
0.02%
-59.6%
Q4 2019$28,000
+27.3%
1,878
+13.5%
0.06%
+18.8%
Q3 2019$22,000
-21.4%
1,655
-2.1%
0.05%
-29.4%
Q2 2019$28,000
+55.6%
1,691
+60.9%
0.07%
-20.9%
Q1 2019$18,0001,0510.09%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders